Approval · Notice of Compliance 490 · 2002
INTEGRILIN: Notice of Compliance 490
Issued June 3, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 490
- Date
- June 3, 2002
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional indication and a new dosing regimen in the treatment of patients undergoing percutaneous transluminal coronary angioplasty
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTEGRILIN | Not yet assigned | — |
Medicinal ingredients
- EPTIFIBATIDE 0.75 MG per ML
- EPTIFIBATIDE 2 MG per ML